Pharmacology and Toxicology of Opioids, 2nd Edition
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 25 November 2025 | Viewed by 610
Special Issue Editors
2. UCIBIO—Applied Molecular Biosciences Unit, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal
Interests: opioid pharmacology; prescription opioids; toxicity assays; toxicity mechanisms; in vivo models; in vitro models
Special Issues, Collections and Topics in MDPI journals
2. UCIBIO—Applied Molecular Biosciences Unit, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal
Interests: toxicology; opioid pharmacology; opioid pharmacokinetics; opioid pharmacodynamics; toxicity biomarkers; adverse outcome pathways; toxicity screening; in vitro assays; in vivo assays
Special Issues, Collections and Topics in MDPI journals
Interests: toxicology; psychoactive substances; forensic sciences; drugs; opioids; biomedical research; scientometrics; scientific medical writing; pedagogical innovation; real-world evidence
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Opioids are a broad group of drugs that include both illegal drugs and medicines. In pharmacological contexts, opioids are currently used as a gold standard for the treatment of moderate to severe pain. Pain is a complex and subjective experience and a symptom associated with several pathologies, many of which are extremely frequent, leading to the widespread consumption of opioids. Despite their high analgesic efficiency, the incidence of side effects and adverse reactions; poisoning cases, including fatal intoxications; and cases of addiction are growing, along with the increase in their use and misuse. In fact, rising opioid consumption is leading to an opioid epidemic and a public health crisis.
In this context, it is important to broaden our knowledge of opioids’ pharmacology and toxicity mechanisms to improve their therapeutic efficacy and lower the rate of adverse effects, which will ultimately improve the quality of life of many patients. Furthermore, it is also important to understand and decrease the potential for opioid dependence in addition to searching for new analgesic opioids. Therefore, in this Special Issue, authors are invited to submit original papers, (mini-)reviews, communications, perspectives, and opinion articles on all relevant aspects of opioid pharmacology and toxicology.
Their research areas may include the following:
- In vitro and in vivo studies on opioid toxicity;
- In vitro and in vivo studies on opioid structure–activity relationships;
- Pharmacokinetic and pharmacodynamic studies;
- Behavioral studies;
- New advancements in opioid pharmacology, including (but not limited to) new opioid drug candidates;
- New opioid quantification methodologies.
Dr. Juliana Faria
Dr. Joana Barbosa
Prof. Dr. Ricardo Dinis-Oliveira
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- opioid toxicity
- opioid pharmacodynamics
- opioid pharmacokinetics
- opioid pharmacogenetics
- prescription opioids
- toxicity assays
- in vivo
- in vitro
- abuse
- dependence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
